Since the inception of chronic hemodialysis and the introduction of the Brescia-Cimino arteriovenous fistula, 1 there has been a strong culture favoring vein preservation in the nephrology and ...
In 2014, Penumbra broke into the peripheral thrombectomy space with the release of the first Indigo System catheters, the 5-F CAT5 catheter and the 3-F CAT3 catheter (Penumbra, Inc.). These were ...
Venous stenting first emerged as a treatment for iliofemoral venous outflow obstruction in the 1990s. Recently, several factors have led to a significant increase in the volume of these procedures ...
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase. 1-3 Although most of these patients ...
Penumbra’s embolization platform is made up of three unique detachable coil technologies: the Ruby® Coil, POD® (Penumbra Occlusion Device), and Packing Coil—all of which are large-volume coils, ...
Investigators share case-based perspectives and trial experiences with the Serranator PTA Serration Balloon Catheter, now FDA-cleared for use below the knee. Chronic limb-threatening ischemia (CLTI) ...
The Vascular Disease Foundation (VDF) was formed in 1998 to improve public recognition of the prevalence and seriousness of vascular disease. It is a national not-for-profit, public 501(c)(3) ...
This article is a companion to “Coding for Lower Extremity Revascularization in 2011,” which was published in Endovascular Today'sMay 2011 issue. In January 2011, 16 new codes were introduced, ...
Experts discuss current evidence and lessons learned, patient candidacy, go-to embolics and devices, barriers to widespread use, predictions for future practice, and more. Prof. Little: GAE has burst ...
First, what are the unique advantages of performing cases in hospitals? What do you see as the biggest disadvantages? Dr. Armstrong: Performing cases in the hospital has a number of advantages. The ...